ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RXRG
|
ENSG00000143171.8 | RXRG |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RXRG | hg19_v2_chr1_-_165414414_165414433 | 0.23 | 3.8e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_116166331 | 3.53 |
ENST00000393468.1 ENST00000393467.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr7_+_116165754 | 3.13 |
ENST00000405348.1 |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
chr1_-_154946825 | 1.68 |
ENST00000368453.4 ENST00000368450.1 ENST00000366442.2 |
SHC1 |
SHC (Src homology 2 domain containing) transforming protein 1 |
chr11_+_10326612 | 1.67 |
ENST00000534464.1 ENST00000530439.1 ENST00000524948.1 ENST00000528655.1 ENST00000526492.1 ENST00000525063.1 |
ADM |
adrenomedullin |
chr9_+_137533615 | 1.64 |
ENST00000371817.3 |
COL5A1 |
collagen, type V, alpha 1 |
chr12_-_106641728 | 1.59 |
ENST00000378026.4 |
CKAP4 |
cytoskeleton-associated protein 4 |
chr15_+_74218787 | 1.42 |
ENST00000261921.7 |
LOXL1 |
lysyl oxidase-like 1 |
chr6_-_132272504 | 1.42 |
ENST00000367976.3 |
CTGF |
connective tissue growth factor |
chr7_+_116139744 | 1.34 |
ENST00000343213.2 |
CAV2 |
caveolin 2 |
chr10_+_54074033 | 1.30 |
ENST00000373970.3 |
DKK1 |
dickkopf WNT signaling pathway inhibitor 1 |
chr22_+_38093005 | 1.20 |
ENST00000406386.3 |
TRIOBP |
TRIO and F-actin binding protein |
chr8_+_26371763 | 1.20 |
ENST00000521913.1 |
DPYSL2 |
dihydropyrimidinase-like 2 |
chr7_-_107643674 | 1.15 |
ENST00000222399.6 |
LAMB1 |
laminin, beta 1 |
chr6_+_29910301 | 1.14 |
ENST00000376809.5 ENST00000376802.2 |
HLA-A |
major histocompatibility complex, class I, A |
chr7_-_94285402 | 1.13 |
ENST00000428696.2 ENST00000445866.2 |
SGCE |
sarcoglycan, epsilon |
chr5_-_131562935 | 1.12 |
ENST00000379104.2 ENST00000379100.2 ENST00000428369.1 |
P4HA2 |
prolyl 4-hydroxylase, alpha polypeptide II |
chr3_-_38691119 | 1.10 |
ENST00000333535.4 ENST00000413689.1 ENST00000443581.1 ENST00000425664.1 ENST00000451551.2 |
SCN5A |
sodium channel, voltage-gated, type V, alpha subunit |
chrX_+_135229600 | 1.03 |
ENST00000370690.3 |
FHL1 |
four and a half LIM domains 1 |
chr7_-_45960850 | 1.01 |
ENST00000381083.4 ENST00000381086.5 ENST00000275521.6 |
IGFBP3 |
insulin-like growth factor binding protein 3 |
chr7_-_94285472 | 0.98 |
ENST00000437425.2 ENST00000447873.1 ENST00000415788.2 |
SGCE |
sarcoglycan, epsilon |
chr10_+_115438920 | 0.93 |
ENST00000429617.1 ENST00000369331.4 |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
chr7_-_94285511 | 0.93 |
ENST00000265735.7 |
SGCE |
sarcoglycan, epsilon |
chr19_-_50143452 | 0.90 |
ENST00000246792.3 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
chrX_-_99891796 | 0.88 |
ENST00000373020.4 |
TSPAN6 |
tetraspanin 6 |
chr9_-_16727978 | 0.86 |
ENST00000418777.1 ENST00000468187.2 |
BNC2 |
basonuclin 2 |
chr17_-_39968406 | 0.85 |
ENST00000393928.1 |
LEPREL4 |
leprecan-like 4 |
chr5_-_55290773 | 0.84 |
ENST00000502326.3 ENST00000381298.2 |
IL6ST |
interleukin 6 signal transducer (gp130, oncostatin M receptor) |
chr3_-_16555150 | 0.83 |
ENST00000334133.4 |
RFTN1 |
raftlin, lipid raft linker 1 |
chr20_+_53092123 | 0.83 |
ENST00000262593.5 |
DOK5 |
docking protein 5 |
chrX_+_135229559 | 0.82 |
ENST00000394155.2 |
FHL1 |
four and a half LIM domains 1 |
chr6_-_138428613 | 0.79 |
ENST00000421351.3 |
PERP |
PERP, TP53 apoptosis effector |
chr1_+_26606608 | 0.79 |
ENST00000319041.6 |
SH3BGRL3 |
SH3 domain binding glutamic acid-rich protein like 3 |
chr12_-_51785182 | 0.77 |
ENST00000356317.3 ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
chrX_+_135229731 | 0.77 |
ENST00000420362.1 |
FHL1 |
four and a half LIM domains 1 |
chr6_-_2971494 | 0.75 |
ENST00000380539.1 |
SERPINB6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
chr3_-_99833333 | 0.74 |
ENST00000354552.3 ENST00000331335.5 ENST00000398326.2 |
FILIP1L |
filamin A interacting protein 1-like |
chr17_-_76921459 | 0.72 |
ENST00000262768.7 |
TIMP2 |
TIMP metallopeptidase inhibitor 2 |
chr9_+_103235365 | 0.72 |
ENST00000374879.4 |
TMEFF1 |
transmembrane protein with EGF-like and two follistatin-like domains 1 |
chr20_-_23066953 | 0.71 |
ENST00000246006.4 |
CD93 |
CD93 molecule |
chr17_-_27278304 | 0.71 |
ENST00000577226.1 |
PHF12 |
PHD finger protein 12 |
chr18_+_56530794 | 0.71 |
ENST00000590285.1 ENST00000586085.1 ENST00000589288.1 |
ZNF532 |
zinc finger protein 532 |
chr12_-_54813229 | 0.71 |
ENST00000293379.4 |
ITGA5 |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chr17_-_39968855 | 0.70 |
ENST00000355468.3 ENST00000590496.1 |
LEPREL4 |
leprecan-like 4 |
chr8_-_93115445 | 0.68 |
ENST00000523629.1 |
RUNX1T1 |
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr5_-_131563501 | 0.67 |
ENST00000401867.1 ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2 |
prolyl 4-hydroxylase, alpha polypeptide II |
chr7_-_151433393 | 0.67 |
ENST00000492843.1 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr7_-_151433342 | 0.67 |
ENST00000433631.2 |
PRKAG2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
chr9_-_13279563 | 0.66 |
ENST00000541718.1 |
MPDZ |
multiple PDZ domain protein |
chr1_-_33168336 | 0.66 |
ENST00000373484.3 |
SYNC |
syncoilin, intermediate filament protein |
chr7_+_143079000 | 0.65 |
ENST00000392910.2 |
ZYX |
zyxin |
chrX_-_153640420 | 0.65 |
ENST00000451865.1 ENST00000432135.1 ENST00000369809.1 ENST00000393638.1 ENST00000424626.1 ENST00000309585.5 |
DNASE1L1 |
deoxyribonuclease I-like 1 |
chr20_+_53092232 | 0.64 |
ENST00000395939.1 |
DOK5 |
docking protein 5 |
chr1_-_109584768 | 0.61 |
ENST00000357672.3 |
WDR47 |
WD repeat domain 47 |
chr20_-_17641097 | 0.60 |
ENST00000246043.4 |
RRBP1 |
ribosome binding protein 1 |
chr19_-_39390440 | 0.60 |
ENST00000249396.7 ENST00000414941.1 ENST00000392081.2 |
SIRT2 |
sirtuin 2 |
chr6_+_143999072 | 0.60 |
ENST00000440869.2 ENST00000367582.3 ENST00000451827.2 |
PHACTR2 |
phosphatase and actin regulator 2 |
chr11_-_86666427 | 0.59 |
ENST00000531380.1 |
FZD4 |
frizzled family receptor 4 |
chr6_+_107811162 | 0.58 |
ENST00000317357.5 |
SOBP |
sine oculis binding protein homolog (Drosophila) |
chr5_+_131593364 | 0.58 |
ENST00000253754.3 ENST00000379018.3 |
PDLIM4 |
PDZ and LIM domain 4 |
chr17_-_1394940 | 0.58 |
ENST00000570984.2 ENST00000361007.2 |
MYO1C |
myosin IC |
chr19_-_43708378 | 0.58 |
ENST00000599746.1 |
PSG4 |
pregnancy specific beta-1-glycoprotein 4 |
chr6_+_142623063 | 0.58 |
ENST00000296932.8 ENST00000367609.3 |
GPR126 |
G protein-coupled receptor 126 |
chr7_+_143078652 | 0.58 |
ENST00000354434.4 ENST00000449423.2 |
ZYX |
zyxin |
chr20_-_56285595 | 0.57 |
ENST00000395816.3 ENST00000347215.4 |
PMEPA1 |
prostate transmembrane protein, androgen induced 1 |
chrX_+_149531524 | 0.57 |
ENST00000370401.2 |
MAMLD1 |
mastermind-like domain containing 1 |
chr21_+_46825032 | 0.57 |
ENST00000400337.2 |
COL18A1 |
collagen, type XVIII, alpha 1 |
chr21_-_46293644 | 0.57 |
ENST00000330938.3 |
PTTG1IP |
pituitary tumor-transforming 1 interacting protein |
chr6_-_52859968 | 0.57 |
ENST00000370959.1 |
GSTA4 |
glutathione S-transferase alpha 4 |
chr4_-_22517620 | 0.56 |
ENST00000502482.1 ENST00000334304.5 |
GPR125 |
G protein-coupled receptor 125 |
chr6_-_2971792 | 0.56 |
ENST00000380546.3 |
SERPINB6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
chr1_-_109584716 | 0.54 |
ENST00000531337.1 ENST00000529074.1 ENST00000369965.4 |
WDR47 |
WD repeat domain 47 |
chr22_-_17680472 | 0.54 |
ENST00000330232.4 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
chr14_+_104095514 | 0.53 |
ENST00000348520.6 ENST00000380038.3 ENST00000389744.4 ENST00000557575.1 ENST00000553286.1 ENST00000347839.6 ENST00000555836.1 ENST00000334553.6 ENST00000246489.7 ENST00000557450.1 ENST00000452929.2 ENST00000554280.1 ENST00000445352.4 |
KLC1 |
kinesin light chain 1 |
chr10_+_76586348 | 0.52 |
ENST00000372724.1 ENST00000287239.4 ENST00000372714.1 |
KAT6B |
K(lysine) acetyltransferase 6B |
chr17_-_40575535 | 0.52 |
ENST00000357037.5 |
PTRF |
polymerase I and transcript release factor |
chr2_-_175629135 | 0.52 |
ENST00000409542.1 ENST00000409219.1 |
CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
chr20_+_62694461 | 0.52 |
ENST00000343484.5 ENST00000395053.3 |
TCEA2 |
transcription elongation factor A (SII), 2 |
chr20_+_11871433 | 0.51 |
ENST00000399006.2 ENST00000405977.1 |
BTBD3 |
BTB (POZ) domain containing 3 |
chr15_-_71146480 | 0.51 |
ENST00000299213.8 |
LARP6 |
La ribonucleoprotein domain family, member 6 |
chr12_-_123755639 | 0.50 |
ENST00000535979.1 |
CDK2AP1 |
cyclin-dependent kinase 2 associated protein 1 |
chr12_-_109251345 | 0.50 |
ENST00000360239.3 ENST00000326495.5 ENST00000551165.1 |
SSH1 |
slingshot protein phosphatase 1 |
chr1_-_113249734 | 0.50 |
ENST00000484054.3 ENST00000369636.2 ENST00000369637.1 ENST00000285735.2 ENST00000369638.2 |
RHOC |
ras homolog family member C |
chr19_-_39390350 | 0.50 |
ENST00000447739.1 ENST00000358931.5 ENST00000407552.1 |
SIRT2 |
sirtuin 2 |
chr11_+_9685604 | 0.50 |
ENST00000447399.2 ENST00000318950.6 |
SWAP70 |
SWAP switching B-cell complex 70kDa subunit |
chr21_-_46293586 | 0.50 |
ENST00000445724.2 ENST00000397887.3 |
PTTG1IP |
pituitary tumor-transforming 1 interacting protein |
chr1_-_109584608 | 0.49 |
ENST00000400794.3 ENST00000528747.1 ENST00000369962.3 ENST00000361054.3 |
WDR47 |
WD repeat domain 47 |
chr12_-_110318226 | 0.49 |
ENST00000544393.1 |
GLTP |
glycolipid transfer protein |
chr20_-_57582296 | 0.49 |
ENST00000217131.5 |
CTSZ |
cathepsin Z |
chr9_-_16870704 | 0.49 |
ENST00000380672.4 ENST00000380667.2 ENST00000380666.2 ENST00000486514.1 |
BNC2 |
basonuclin 2 |
chr12_-_110318263 | 0.49 |
ENST00000318348.4 |
GLTP |
glycolipid transfer protein |
chr2_+_172544182 | 0.49 |
ENST00000409197.1 ENST00000456808.1 ENST00000409317.1 ENST00000409773.1 ENST00000411953.1 ENST00000409453.1 |
DYNC1I2 |
dynein, cytoplasmic 1, intermediate chain 2 |
chrX_-_37706815 | 0.49 |
ENST00000378578.4 |
DYNLT3 |
dynein, light chain, Tctex-type 3 |
chr20_+_62694590 | 0.48 |
ENST00000339217.4 |
TCEA2 |
transcription elongation factor A (SII), 2 |
chr1_-_155881156 | 0.48 |
ENST00000539040.1 ENST00000368323.3 |
RIT1 |
Ras-like without CAAX 1 |
chr5_+_170288856 | 0.46 |
ENST00000523189.1 |
RANBP17 |
RAN binding protein 17 |
chr17_-_46688334 | 0.46 |
ENST00000239165.7 |
HOXB7 |
homeobox B7 |
chr2_+_46524537 | 0.45 |
ENST00000263734.3 |
EPAS1 |
endothelial PAS domain protein 1 |
chr2_-_37899323 | 0.45 |
ENST00000295324.3 ENST00000457889.1 |
CDC42EP3 |
CDC42 effector protein (Rho GTPase binding) 3 |
chr6_-_46459099 | 0.45 |
ENST00000371374.1 |
RCAN2 |
regulator of calcineurin 2 |
chr15_+_67430339 | 0.45 |
ENST00000439724.3 |
SMAD3 |
SMAD family member 3 |
chr2_+_191208196 | 0.44 |
ENST00000392329.2 ENST00000322522.4 ENST00000430311.1 ENST00000541441.1 |
INPP1 |
inositol polyphosphate-1-phosphatase |
chr9_+_139873264 | 0.44 |
ENST00000446677.1 |
PTGDS |
prostaglandin D2 synthase 21kDa (brain) |
chr2_-_242255117 | 0.44 |
ENST00000420451.1 ENST00000417540.1 ENST00000310931.4 |
HDLBP |
high density lipoprotein binding protein |
chr11_+_129939811 | 0.44 |
ENST00000345598.5 ENST00000338167.5 |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
chr11_+_129939779 | 0.43 |
ENST00000533195.1 ENST00000533713.1 ENST00000528499.1 ENST00000539648.1 ENST00000263574.5 |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
chr9_-_110251836 | 0.43 |
ENST00000374672.4 |
KLF4 |
Kruppel-like factor 4 (gut) |
chr2_+_172544294 | 0.42 |
ENST00000358002.6 ENST00000435234.1 ENST00000443458.1 ENST00000412370.1 |
DYNC1I2 |
dynein, cytoplasmic 1, intermediate chain 2 |
chr17_+_39975455 | 0.42 |
ENST00000455106.1 |
FKBP10 |
FK506 binding protein 10, 65 kDa |
chr17_+_2240775 | 0.42 |
ENST00000268989.3 ENST00000426855.2 |
SGSM2 |
small G protein signaling modulator 2 |
chr1_+_156052354 | 0.42 |
ENST00000368301.2 |
LMNA |
lamin A/C |
chr19_-_14228541 | 0.42 |
ENST00000590853.1 ENST00000308677.4 |
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha |
chr22_+_31489344 | 0.41 |
ENST00000404574.1 |
SMTN |
smoothelin |
chr1_-_203144941 | 0.41 |
ENST00000255416.4 |
MYBPH |
myosin binding protein H |
chrX_+_55478538 | 0.41 |
ENST00000342972.1 |
MAGEH1 |
melanoma antigen family H, 1 |
chr1_+_23037323 | 0.41 |
ENST00000544305.1 ENST00000374630.3 ENST00000400191.3 ENST00000374632.3 |
EPHB2 |
EPH receptor B2 |
chr6_-_33267101 | 0.41 |
ENST00000497454.1 |
RGL2 |
ral guanine nucleotide dissociation stimulator-like 2 |
chr20_-_36793774 | 0.41 |
ENST00000361475.2 |
TGM2 |
transglutaminase 2 |
chr2_+_46926326 | 0.41 |
ENST00000394861.2 |
SOCS5 |
suppressor of cytokine signaling 5 |
chr6_-_84140757 | 0.40 |
ENST00000541327.1 ENST00000369705.3 ENST00000543031.1 |
ME1 |
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr17_+_39975544 | 0.40 |
ENST00000544340.1 |
FKBP10 |
FK506 binding protein 10, 65 kDa |
chr14_+_58765103 | 0.39 |
ENST00000355431.3 ENST00000348476.3 ENST00000395168.3 |
ARID4A |
AT rich interactive domain 4A (RBP1-like) |
chr8_-_26371608 | 0.39 |
ENST00000522362.2 |
PNMA2 |
paraneoplastic Ma antigen 2 |
chr1_-_113249678 | 0.39 |
ENST00000369633.2 ENST00000425265.2 ENST00000369632.2 ENST00000436685.2 |
RHOC |
ras homolog family member C |
chr17_-_80291818 | 0.38 |
ENST00000269389.3 ENST00000581691.1 |
SECTM1 |
secreted and transmembrane 1 |
chr2_-_202316260 | 0.38 |
ENST00000332624.3 |
TRAK2 |
trafficking protein, kinesin binding 2 |
chr6_-_110500905 | 0.38 |
ENST00000392587.2 |
WASF1 |
WAS protein family, member 1 |
chr6_+_53659746 | 0.38 |
ENST00000370888.1 |
LRRC1 |
leucine rich repeat containing 1 |
chr3_-_178789993 | 0.38 |
ENST00000432729.1 |
ZMAT3 |
zinc finger, matrin-type 3 |
chr17_+_40811283 | 0.38 |
ENST00000251412.7 |
TUBG2 |
tubulin, gamma 2 |
chr13_+_37006421 | 0.38 |
ENST00000255465.4 |
CCNA1 |
cyclin A1 |
chr8_-_70983506 | 0.37 |
ENST00000276594.2 |
PRDM14 |
PR domain containing 14 |
chr19_+_4304585 | 0.37 |
ENST00000221856.6 |
FSD1 |
fibronectin type III and SPRY domain containing 1 |
chr11_-_62380199 | 0.37 |
ENST00000419857.1 ENST00000394773.2 |
EML3 |
echinoderm microtubule associated protein like 3 |
chr9_+_34653861 | 0.37 |
ENST00000556792.1 ENST00000318041.9 ENST00000378817.4 |
IL11RA |
interleukin 11 receptor, alpha |
chr11_+_66036004 | 0.37 |
ENST00000311481.6 ENST00000527397.1 |
RAB1B |
RAB1B, member RAS oncogene family |
chr6_-_80657292 | 0.36 |
ENST00000369816.4 |
ELOVL4 |
ELOVL fatty acid elongase 4 |
chr9_-_13279406 | 0.36 |
ENST00000546205.1 |
MPDZ |
multiple PDZ domain protein |
chr17_-_2304365 | 0.36 |
ENST00000575394.1 ENST00000174618.4 |
MNT |
MAX network transcriptional repressor |
chr11_+_43702236 | 0.36 |
ENST00000531185.1 ENST00000278353.4 |
HSD17B12 |
hydroxysteroid (17-beta) dehydrogenase 12 |
chr17_+_59477233 | 0.36 |
ENST00000240328.3 |
TBX2 |
T-box 2 |
chr6_-_2971429 | 0.35 |
ENST00000380529.1 |
SERPINB6 |
serpin peptidase inhibitor, clade B (ovalbumin), member 6 |
chr12_+_6833437 | 0.35 |
ENST00000534947.1 ENST00000541866.1 ENST00000534877.1 ENST00000538753.1 |
COPS7A |
COP9 signalosome subunit 7A |
chr4_+_668348 | 0.35 |
ENST00000511290.1 |
MYL5 |
myosin, light chain 5, regulatory |
chr2_-_230786679 | 0.35 |
ENST00000543084.1 ENST00000343290.5 ENST00000389044.4 ENST00000283943.5 |
TRIP12 |
thyroid hormone receptor interactor 12 |
chr10_-_79398250 | 0.35 |
ENST00000286627.5 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr19_-_15560730 | 0.35 |
ENST00000389282.4 ENST00000263381.7 |
WIZ |
widely interspaced zinc finger motifs |
chr21_-_46707793 | 0.34 |
ENST00000331343.7 ENST00000349485.5 |
POFUT2 |
protein O-fucosyltransferase 2 |
chr1_-_65432171 | 0.34 |
ENST00000342505.4 |
JAK1 |
Janus kinase 1 |
chr15_+_67458357 | 0.34 |
ENST00000537194.2 |
SMAD3 |
SMAD family member 3 |
chr19_+_676385 | 0.34 |
ENST00000166139.4 |
FSTL3 |
follistatin-like 3 (secreted glycoprotein) |
chr1_-_113249948 | 0.34 |
ENST00000339083.7 ENST00000369642.3 |
RHOC |
ras homolog family member C |
chr13_+_37005967 | 0.34 |
ENST00000440264.1 ENST00000449823.1 |
CCNA1 |
cyclin A1 |
chrX_+_153672468 | 0.34 |
ENST00000393600.3 |
FAM50A |
family with sequence similarity 50, member A |
chr17_+_39969183 | 0.33 |
ENST00000321562.4 |
FKBP10 |
FK506 binding protein 10, 65 kDa |
chr4_+_20255123 | 0.33 |
ENST00000504154.1 ENST00000273739.5 |
SLIT2 |
slit homolog 2 (Drosophila) |
chr12_-_96794330 | 0.33 |
ENST00000261211.3 |
CDK17 |
cyclin-dependent kinase 17 |
chr13_+_37006398 | 0.32 |
ENST00000418263.1 |
CCNA1 |
cyclin A1 |
chr11_+_44117741 | 0.32 |
ENST00000395673.3 ENST00000343631.3 |
EXT2 |
exostosin glycosyltransferase 2 |
chr10_-_75255668 | 0.32 |
ENST00000545874.1 |
PPP3CB |
protein phosphatase 3, catalytic subunit, beta isozyme |
chr3_-_121468513 | 0.32 |
ENST00000494517.1 ENST00000393667.3 |
GOLGB1 |
golgin B1 |
chr22_+_47158578 | 0.31 |
ENST00000355704.3 |
TBC1D22A |
TBC1 domain family, member 22A |
chr4_-_85887503 | 0.31 |
ENST00000509172.1 ENST00000322366.6 ENST00000295888.4 ENST00000502713.1 |
WDFY3 |
WD repeat and FYVE domain containing 3 |
chr22_+_47158518 | 0.31 |
ENST00000337137.4 ENST00000380995.1 ENST00000407381.3 |
TBC1D22A |
TBC1 domain family, member 22A |
chr7_+_114562172 | 0.31 |
ENST00000393486.1 ENST00000257724.3 |
MDFIC |
MyoD family inhibitor domain containing |
chr2_+_242255275 | 0.31 |
ENST00000391971.2 |
SEPT2 |
septin 2 |
chr3_-_50329835 | 0.31 |
ENST00000429673.2 |
IFRD2 |
interferon-related developmental regulator 2 |
chr17_+_42264322 | 0.30 |
ENST00000446571.3 ENST00000357984.3 ENST00000538716.2 |
TMUB2 |
transmembrane and ubiquitin-like domain containing 2 |
chr3_-_178790057 | 0.30 |
ENST00000311417.2 |
ZMAT3 |
zinc finger, matrin-type 3 |
chr19_-_46000251 | 0.29 |
ENST00000590526.1 ENST00000344680.4 ENST00000245923.4 |
RTN2 |
reticulon 2 |
chr11_+_124609823 | 0.29 |
ENST00000412681.2 |
NRGN |
neurogranin (protein kinase C substrate, RC3) |
chr13_-_41240717 | 0.29 |
ENST00000379561.5 |
FOXO1 |
forkhead box O1 |
chr11_+_44117260 | 0.29 |
ENST00000358681.4 |
EXT2 |
exostosin glycosyltransferase 2 |
chr17_+_45727204 | 0.28 |
ENST00000290158.4 |
KPNB1 |
karyopherin (importin) beta 1 |
chr19_+_4304632 | 0.28 |
ENST00000597590.1 |
FSD1 |
fibronectin type III and SPRY domain containing 1 |
chr15_+_49170083 | 0.28 |
ENST00000530028.2 |
EID1 |
EP300 interacting inhibitor of differentiation 1 |
chr3_-_121468602 | 0.28 |
ENST00000340645.5 |
GOLGB1 |
golgin B1 |
chr1_+_202317815 | 0.28 |
ENST00000608999.1 ENST00000336894.4 ENST00000480184.1 |
PPP1R12B |
protein phosphatase 1, regulatory subunit 12B |
chr19_+_39390587 | 0.27 |
ENST00000572515.1 ENST00000392079.3 ENST00000575359.1 ENST00000313582.5 |
NFKBIB |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
chr2_+_120124497 | 0.27 |
ENST00000355857.3 ENST00000535617.1 ENST00000535757.1 ENST00000409094.1 ENST00000311521.4 |
DBI |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
chr10_-_79397391 | 0.26 |
ENST00000286628.8 ENST00000406533.3 ENST00000354353.5 ENST00000404857.1 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr14_-_89883412 | 0.26 |
ENST00000557258.1 |
FOXN3 |
forkhead box N3 |
chr22_+_38201114 | 0.26 |
ENST00000340857.2 |
H1F0 |
H1 histone family, member 0 |
chr19_+_52693259 | 0.26 |
ENST00000322088.6 ENST00000454220.2 ENST00000444322.2 ENST00000477989.1 |
PPP2R1A |
protein phosphatase 2, regulatory subunit A, alpha |
chr2_-_175629164 | 0.25 |
ENST00000409323.1 ENST00000261007.5 ENST00000348749.5 |
CHRNA1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
chr12_-_48152428 | 0.25 |
ENST00000449771.2 ENST00000395358.3 |
RAPGEF3 |
Rap guanine nucleotide exchange factor (GEF) 3 |
chr4_-_90758118 | 0.25 |
ENST00000420646.2 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr19_+_7968728 | 0.25 |
ENST00000397981.3 ENST00000545011.1 ENST00000397983.3 ENST00000397979.3 |
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
chr12_-_57940904 | 0.25 |
ENST00000550954.1 ENST00000434715.3 ENST00000546670.1 ENST00000543672.1 |
DCTN2 |
dynactin 2 (p50) |
chr14_+_24867992 | 0.25 |
ENST00000382554.3 |
NYNRIN |
NYN domain and retroviral integrase containing |
chr10_-_79397479 | 0.25 |
ENST00000404771.3 |
KCNMA1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
chr4_-_90758227 | 0.25 |
ENST00000506691.1 ENST00000394986.1 ENST00000506244.1 ENST00000394989.2 ENST00000394991.3 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr3_-_48130314 | 0.24 |
ENST00000439356.1 ENST00000395734.3 ENST00000426837.2 |
MAP4 |
microtubule-associated protein 4 |
chrX_+_153686614 | 0.24 |
ENST00000369682.3 |
PLXNA3 |
plexin A3 |
chr7_+_116312411 | 0.24 |
ENST00000456159.1 ENST00000397752.3 ENST00000318493.6 |
MET |
met proto-oncogene |
chr19_+_54606145 | 0.24 |
ENST00000485876.1 ENST00000391762.1 ENST00000471292.1 ENST00000391763.3 ENST00000391764.3 ENST00000303553.5 |
NDUFA3 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa |
chr11_+_125774362 | 0.24 |
ENST00000530414.1 ENST00000530129.2 |
DDX25 |
DEAD (Asp-Glu-Ala-Asp) box helicase 25 |
chr3_-_88108192 | 0.24 |
ENST00000309534.6 |
CGGBP1 |
CGG triplet repeat binding protein 1 |
chr12_-_57941004 | 0.24 |
ENST00000550750.1 ENST00000548249.1 |
DCTN2 |
dynactin 2 (p50) |
chr10_-_81205373 | 0.24 |
ENST00000372336.3 |
ZCCHC24 |
zinc finger, CCHC domain containing 24 |
chrX_+_38420623 | 0.24 |
ENST00000378482.2 |
TSPAN7 |
tetraspanin 7 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 6.8 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.9 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 1.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.0 | 1.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 3.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 2.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.6 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.3 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.2 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 4.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 7.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 1.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.1 | 1.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 1.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 1.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 1.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 1.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.8 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 1.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 1.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.9 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.5 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.1 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
0.0 | 0.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.6 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 1.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.2 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.4 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 1.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.0 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.0 | 0.2 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.4 | 1.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.4 | 1.1 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.4 | 1.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.4 | 1.8 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 0.8 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) oncostatin-M receptor activity(GO:0004924) interleukin-6 binding(GO:0019981) |
0.2 | 1.7 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 1.3 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 0.8 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 0.6 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.1 | 1.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 1.3 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.1 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 0.3 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 0.3 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.1 | 0.4 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.1 | 0.7 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 0.5 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.1 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 0.4 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 1.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 0.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.4 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.3 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) fucose binding(GO:0042806) |
0.1 | 0.4 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) oxaloacetate decarboxylase activity(GO:0008948) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.4 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.9 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 1.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.0 | 0.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 0.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.0 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.0 | 0.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
0.0 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.1 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.0 | 0.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.1 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.0 | 0.3 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 2.5 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.3 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.7 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 0.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.4 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.5 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.2 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.8 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 0.1 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.2 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.2 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.0 | 1.1 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 2.4 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.1 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.2 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.0 | 0.1 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.0 | 0.1 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.9 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 6.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.4 | 1.2 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.4 | 3.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.7 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 1.0 | GO:0097123 | cyclin A1-CDK2 complex(GO:0097123) |
0.2 | 0.7 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.2 | 0.6 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 0.6 | GO:0045160 | myosin I complex(GO:0045160) |
0.1 | 1.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 1.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 1.6 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 2.0 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.5 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.0 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 1.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.3 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 1.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 1.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.5 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.3 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 0.5 | GO:0097227 | sperm annulus(GO:0097227) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 2.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.4 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.8 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.7 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.1 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.0 | 2.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.2 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.6 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.2 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 2.2 | GO:0035580 | specific granule lumen(GO:0035580) |
0.0 | 0.3 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.2 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.5 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.0 | 0.1 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 0.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.0 | 0.4 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.5 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.4 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.0 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.4 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.0 | GO:0071159 | NF-kappaB complex(GO:0071159) |
0.0 | 1.4 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 1.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.7 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.1 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.4 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 3.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 6.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.1 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.0 | 1.4 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.1 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.0 | 0.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
0.7 | 2.9 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.5 | 1.4 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.4 | 1.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 1.1 | GO:2000777 | positive regulation of oocyte maturation(GO:1900195) negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.3 | 1.3 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.3 | 1.7 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 1.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 1.2 | GO:0030047 | actin modification(GO:0030047) |
0.2 | 0.8 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 1.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.2 | 0.6 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.2 | 0.5 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.2 | 1.0 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.2 | 0.8 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.6 | GO:0061304 | extracellular matrix-cell signaling(GO:0035426) retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.7 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.1 | 0.4 | GO:0071409 | negative regulation of muscle hyperplasia(GO:0014740) cellular response to cycloheximide(GO:0071409) |
0.1 | 0.5 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.1 | 0.4 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.1 | 0.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 1.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.8 | GO:0032596 | protein transport within lipid bilayer(GO:0032594) protein transport into membrane raft(GO:0032596) |
0.1 | 0.9 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.1 | 1.3 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.1 | 1.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.3 | GO:0021966 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) corticospinal neuron axon guidance(GO:0021966) regulation of negative chemotaxis(GO:0050923) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.1 | 1.7 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.5 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 0.5 | GO:0051621 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
0.1 | 0.4 | GO:0097368 | histone H4-K20 trimethylation(GO:0034773) establishment of Sertoli cell barrier(GO:0097368) |
0.1 | 0.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 0.8 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.1 | 0.3 | GO:1905068 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.4 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 1.0 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.4 | GO:1901628 | positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
0.1 | 0.4 | GO:0035947 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) |
0.1 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.4 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 0.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.3 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.9 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.5 | GO:1901314 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.8 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 0.4 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.1 | 0.3 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.1 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 0.7 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.3 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.1 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.1 | 0.3 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.2 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.1 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.1 | 0.2 | GO:0060974 | neural crest cell migration involved in heart formation(GO:0003147) cell migration involved in heart formation(GO:0060974) anterior neural tube closure(GO:0061713) |
0.1 | 0.4 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.4 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.1 | 1.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.2 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.1 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.8 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.4 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.2 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
0.1 | 0.5 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
0.1 | 2.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 1.4 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 0.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.0 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 1.5 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.2 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.0 | 0.3 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.1 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.0 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 1.0 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.0 | 0.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.0 | 0.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.2 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.3 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.3 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.2 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.0 | 0.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.0 | 0.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) cellular alkene metabolic process(GO:0043449) |
0.0 | 1.1 | GO:1902254 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
0.0 | 0.1 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.6 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.0 | 0.1 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.0 | 0.1 | GO:0032972 | diaphragm contraction(GO:0002086) regulation of muscle filament sliding speed(GO:0032972) |
0.0 | 0.1 | GO:0061743 | motor learning(GO:0061743) |
0.0 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.0 | 1.5 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.0 | 0.2 | GO:1902287 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.0 | 0.3 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.1 | GO:0071306 | cellular response to vitamin E(GO:0071306) negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.0 | 0.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.0 | 0.2 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.0 | 0.4 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 1.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.3 | GO:0017085 | response to insecticide(GO:0017085) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.2 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.0 | 0.1 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.0 | 0.1 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.0 | 0.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.0 | 1.0 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.1 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.3 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.7 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.1 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.0 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.1 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.0 | 0.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.0 | 0.1 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.8 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.0 | 0.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 0.2 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.1 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.4 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.0 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.1 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 0.2 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.6 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.0 | 3.8 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
0.0 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.0 | 0.1 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.5 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.0 | 0.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 0.4 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.4 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.7 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.2 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.2 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.5 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.3 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 1.0 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.3 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.0 | 0.2 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
0.0 | 0.1 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.1 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.0 | 0.0 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.0 | 0.5 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.2 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.7 | GO:0042116 | macrophage activation(GO:0042116) |
0.0 | 0.3 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.1 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.0 | 0.2 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.2 | GO:0019054 | modulation by virus of host process(GO:0019054) |